Compositions for senile diabetes patient blood sugar and blood fat reduction
A blood sugar, human body technology, applied in the direction of drug combination, active ingredients of heterocyclic compounds, metabolic diseases, etc., can solve the problem of unsolved type II diabetes, and achieve the effect of conforming to the physiological state of the human body, increasing sensitivity, and reducing insulin resistance.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0049] Preparation method of the composition:
[0050] In the present invention, the above-mentioned various free amino acids can be purchased from a number of biopharmaceutical companies, or can be prepared by hydrolyzing protein with proteinase from high-quality proteins such as casein white and soybean protein by using the method of protein hydrolysis. The preparation methods are known methods.
[0051] The synthetic method of chromium trippicolinate is disclosed in U.S. Patent (US5,087,623). Chromium trippicolinate can be purchased as a commercial product in many pharmaceutical companies.
[0052] For oral administration, various free amino acids and tripicolinic acid in the above embodiments can be provided in the form of tablets, aqueous or oily suspensions, dispersible powders or granules, emulsions, hard or soft capsules, syrups or elixirs. Compositions for oral administration may be prepared by any of the methods known in the art for the manufacture of pharmaceutical...
Embodiment
[0064] The composite capsule prepared from the composition of the invention is used for clinical trials. Carry out randomized double-blind clinical experiment to 20 type II diabetics, 1 / 2 patient takes orally the compound capsule of composition of the present invention every day, contains 1000mg arginine, 1000mg lysine, 250mg L-glutamine in daily dosage, 500μg chromium tripicolinate (take 5 compound capsules every day, each capsule contains 200mg arginine, 200mg lysine, 50mg glutamine, 100μg chromium tripicolinate). Another 1 / 2 takes placebo, takes 6 months by above-mentioned dosage, measures glycated hemoglobin (HBA1C) and weighing respectively when this experiment begins and ends, after this experiment finishes, the patient who takes composition of the present invention, glycosylation Hemoglobin decreased by an average of 15% and body weight decreased by 8%. In contrast, the changes in these parameters were not statistically significant in patients taking daily placebo.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com